Generic firms club together to take on big pharma patents – The Pharma Letter
Generic firms club together to take on big pharma patents The Pharma Letter The end of a drug’s exclusivity period can result in expensive patent litigation, and IP lawyer Kent Walker has identified an emerging trend that could present.